Positive surgical margins, systemic disease, and prostate cancer-specific mortality

Researchers at the Mayo Clinic have queried their large, nearly 20-year-long database of men who have undergone radical prostatectomy in an attempt to assess the correlation between positive surgical margins at the time of surgery and subsequent occurence of systemic disease or prostate cancer-specific mortality.

A new way to look at side effects of first-line prostate cancer treatment

Academic research into the side effects of different treatments for localized prostate cancer have long been hampered by the lack of consistently used criteria for the assessment of those side effects at baseline and at defined time-periods post-treatment.

The role of radical prostatectomy in older males with high-risk prostate cancer

Data reported earlier this year from the PIVOT study and separately from the long-term Scandinavian study have shown that the surgical treatment of prostate cancer in the patients enrolled in these trials showed no median prostate-cancer specific or overall survival benefit compared to watchful waiting in patients of > 65 years of age.

Risk stratification of men with high-risk prostate cancer prior to first-line surgery

A new French study has attempted to provide a better appreciation of the effect of predictive factors on the biochemical recurrence-free and overall survival of patients with high-risk prostate cancer after a radical prostatectomy (RP).

Long-term QoL of men in the Scandinavian Prostate Cancer Group 4 clinical trial

In 1989 the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) started randomizing men with a clinically initiated diagnosis of localized prostate cancer to either watchful waiting or open radical prostatectomy as their primary treatment. A new paper has now addressed the long-term quality of life (QoL) of men in this study.

Immediate adjuvant therapy for men with positive surgical margins after RP

There are no absolute guidelines as to which patients who have positive surgical margins after a radical prostatectomy (RP) are most appropriate for immediate adjuvant radiation therapy (with or without neoadjuvant and/or adjuvant hormone therapy).

Incidence of climacturia “surprising” to one leading surgeon

It is sometimes amazing how little some physicians appear to understand about the side effects of the treatments that they give to their patients! If these were really rare side effects it might be understandable, but the one we shall discuss below is far from rare …

Retrospective cohort analysis shows mortality benefit in prostate cancer (but there’s a big “however”)

A new report in European Urology may offer some insights into the value of large, retrospective data analyses as compared to multi-center, randomized clinical trials when it comes to the assessment of the effects of different first-line treatments on the management of clinically localized prostate cancer.

Are clinical benefits of RALP being over-hyped to unsuspecting prostate cancer patients?

Back in March, a group of authors from three major medical centers published a report in the Journal for Healthcare Quality strongly suggesting that U.S. hospitals were inappropriately over-promoting the  use of robot-assisted surgery for treatment of prostate cancer.

Kegel exercises, incontinence, training, and recovery of continence after RP

A new study just published in The Lancet has reported that  — among men who have urinary incontinence 6 weeks after a radical prostatectomy (RP) — formal one-on-one training of patients by expert therapists does not in fact reduce the rate of continence at 12 months compared to patients in a control group.

Climacturia as a side effect of radical prostatectomy

“Climacturia” is the involuntary release of urine at the time of orgasm during sexual activity. A new paper by a Swedish research team has expanded our understanding of the prevalence of this problem among men after surgery for localized prostate cancer.

(At least in Ontario) it’s not about where you have your surgery

Over the years, data have clearly shown that where a patient has surgical treatment for localized prostate cancer has little impact on short- and long-term outcomes (although who carries out the surgery very definitely does).

PSA monitoring after prostate cancer surgery: how long is long enough?

A paper currently “in press” in the Journal of Urology suggests that annual PSA testing “may be safely discontinued after 10 years for men with a prostatectomy Gleason score 6 or less and/or limited life expectancy.”

A current review of the side effects of radical prostatectomy

A Swedish research team has reviewed recent published data on the side effects of radical prostatectomy. While they suggest that there have been improvements in several areas since the situation in the 1990s, they are very clear that there is still a series of significant risks associated with radical surgery as a treatment for prostate [...]

Age and risk for incontinence after radical prostatectomy

A new analysis of data from a large, consecutive series of Swedish patients suggests a very strong correlation between age at time of radical prostatectomy and risk for significant, long-term urinary leakage.

Follow

Get every new post delivered to your Inbox.

Join 332 other followers